| 查看: 1899 | 回复: 5 | |||
[交流]
【讨论】非索非那定的市场情况
|
|
求：非索非那定的 一、产品研发背景 1. 原研厂家 2. 研发时间与研究立意 3.国外的上市与销售情况 二、与现有竞争产品的比较 三、国内市场情况 1.批文数量及厂家（含规格） 2. 历史销售情况及分析 3.国内主要生产厂家的销售情况 |
回复此楼» 猜你喜欢
如何理解hopf map
已经有0人回复
-
提取肿瘤组织消化后得到的肿瘤细胞死亡率过高
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有126人回复
-
WoS一区Frontiers in Genome Editing基因编辑方法与应用方向专题邀稿（影响因子4.9）
已经有0人回复
-
WoS一区Frontiers in Genome Editing基因编辑方法与应用方向专题邀稿（影响因子4.9）
已经有0人回复
-
WoS一区Frontiers in Genome Editing基因编辑方法与应用方向专题邀稿（影响因子4.9）
已经有0人回复
-
WoS一区Frontiers in Genome Editing基因编辑方法与应用方向专题邀稿（影响因子4.9）
已经有0人回复
-
跪求一支AAV293细胞
已经有1人回复
-
博导推荐
已经有2人回复
-
哪里做甘氨酸受体与配体结合率的试验
已经有0人回复
-
关于SCI杂志发表挂名
已经有32人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- 现在国内有那几家在生产毒莠定？市场情况如何？
已经有4人回复
» 抢金币啦！回帖就可以得到:
-
2027年博士生（硕博连读/直博）吉林大学-苏州国家实验室光电半导体智能设计与应用团队
+1/476
-
实验室用简易工装、夹具、模具、测试板
+1/82
-
具有超高耐腐蚀性的铝合金阳极氧化后处理工艺
+1/82
-
药化高级研究员
+1/81
-
★★★中山大学（深圳）院士团队招收27届推免硕士生（低维材料与器件方向）
+1/79
-
化工学院邱惠斌教授联合同仁医院招聘博士后
+1/74
-
祈福面上好运，散金币
+1/46
-
中科院东莞材料所依托中科大招收2027届推免生
+1/36
-
大连理工大学化学学院界面介导黏附与组装课题组招收2027级推免生/考研生
+1/29
-
西安交通大学补亚忠课题组招聘2027年博士生
+1/27
-
武汉大学集成与超构光子芯片团队招收博士生
+5/25
-
招生宣讲会倒计时！7月29日20：00，不见不散！
+1/10
-
【香港城市大学】范战西教授课题组现招收博士生（全奖, 2027年秋季入学）
+1/7
-
国家自然科学基金申报者发榜前心理状态调查，麻烦帮忙填一下哇！
+1/5
-
浙江大学医学院附属妇产科医院张霈婧课题组招科研助理——生物信息方向
+2/4
-
（Scopus期刊）Biofunctional Materials《生物功能性材料》招募青年编委及征稿
+1/4
-
2027年硕士推免生 招生--哈尔滨工业大学王磊
+1/4
-
致每一位等待国自然结果的科研人：我们想听听你的心声
+1/4
-
宁波诺丁汉大学新能源与环境材料技术研究中心招收2027年春季入学博士生
+1/3
-
大家有research gate的账号吗？有偿借用
+1/2
2楼2011-03-18 12:51:27
★ ★ ★
warlen(金币+1): 谢谢参与 2011-03-18 15:54:09
空城若虚(金币+40): 非常感谢！ 2011-03-18 20:13:20
caoyuan521(金币+2): 谢谢参与！ 2011-03-18 21:04:15
warlen(金币+1): 谢谢参与 2011-03-18 15:54:09
空城若虚(金币+40): 非常感谢！ 2011-03-18 20:13:20
caoyuan521(金币+2): 谢谢参与！ 2011-03-18 21:04:15
|
Fexofenadine hydrochloride Cas number: 153439-40-8, 138452-21-8 - General description: Fexofenadine (trade names Allegra, Telfast, Fastofen, Tilfur, Vifas, Telfexo, Allerfexo) is an antihistamine drug used in the treatment of hayfever and similar allergy symptoms. It was developed as a successor of and alternative to terfenadine (trade names include Triludan and Seldane), an antihistamine which caused QT interval prolongation, potentially leading to cardiac arrhythmia. It has been described as both second-generation[3] and third-generation antihistamine. The older antihistaminic agent terfenadine was found to metabolize into the related carboxylic acid, fexofenadine. Fexofenadine was found to retain all of the biological activity of its parent while giving fewer adverse reactions in patients, so terfenadine was replaced in the market by its metabolite.[8] Fexofenadine was originally synthesized in 1993 by Massachusetts-based biotechnology company Sepracor, which then sold the development rights to Hoechst Marion Roussel (now part of Sanofi-Aventis), and was later approved by the Food and Drug Administration (FDA) in 1996. AMRI holds the patents to the intermediates and production of fexofenadine HCl along with Roussel. Since that time, it has achieved blockbuster drug status with global sales of $1.87B USD in 2004 (with $1.49B USD coming from the United States). AMRI received royalty payments from Aventis that enabled the growth of AMRI. On January 25, 2011, the FDA approved over-the-counter sales of fexofenadine in the United States, with Sanofi-Aventis' version expected to become available on March 4, 2011. I. Originator:Aventis Pharma, Sepracor; Marketer: ViroPharma; Reference patent: JP 1996502022; WO 9321156; II. Main Competitors in U.S: N021963 Yes FEXOFENADINE HYDROCHLORIDE SUSPENSION; ORAL 30MG/5ML ALLEGRA SANOFI AVENTIS US -------------------------------------------------------------------------------- A076191 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE BARR -------------------------------------------------------------------------------- A076191 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE BARR -------------------------------------------------------------------------------- A076191 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE BARR -------------------------------------------------------------------------------- A076502 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE DR REDDYS LABS LTD -------------------------------------------------------------------------------- A076502 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE DR REDDYS LABS LTD -------------------------------------------------------------------------------- A076502 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE DR REDDYS LABS LTD -------------------------------------------------------------------------------- A077081 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE MYLAN -------------------------------------------------------------------------------- A077081 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE MYLAN -------------------------------------------------------------------------------- A077081 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE MYLAN -------------------------------------------------------------------------------- A076447 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 180MG FEXOFENADINE HYDROCHLORIDE TEVA -------------------------------------------------------------------------------- A076447 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 30MG FEXOFENADINE HYDROCHLORIDE TEVA -------------------------------------------------------------------------------- A076447 AB No FEXOFENADINE HYDROCHLORIDE TABLET; ORAL 60MG FEXOFENADINE HYDROCHLORIDE TEVA -------------------------------------------------------------------------------- A076236 AB No FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 60MG;120MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE BARR -------------------------------------------------------------------------------- A079043 No FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 180MG;240MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE DR REDDYS LABS LTD -------------------------------------------------------------------------------- A076298 AB No FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL 60MG;120MG FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE IMPAX PHARMS III. China Domestic Market I suggest you to look through the SFDA website to get related informations. It is not difficult. IV. The market information is not easy to acquire. I suggest you to purchase IMS data or BMI data. |
3楼2011-03-18 13:36:14
4楼2011-03-18 20:10:17
我主要是为了赚BB5楼2011-03-18 21:35:10
6楼2011-03-29 08:47:19